GRAL · GRAIL Inc
United States · RS rating 98 · As of 2026-10-14
| Price | 139.70 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 99 / 97 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 54 / 50 / 45 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | +0.8% |
| Sales growth Q/Q | +20.4% |
| Distance from 52-week high | +9.3% |
| Market cap (USD) | $2.1B |